A detailed history of Perritt Capital Management Inc transactions in Biote Corp. stock. As of the latest transaction made, Perritt Capital Management Inc holds 127,850 shares of BTMD stock, worth $377,157. This represents 0.29% of its overall portfolio holdings.

Number of Shares
127,850
Previous 513,957 75.12%
Holding current value
$377,157
Previous $2.07 Million 75.17%
% of portfolio
0.29%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$3.25 - $4.28 $1.25 Million - $1.65 Million
-386,107 Reduced 75.12%
127,850 $513,000
Q2 2025

Aug 12, 2025

BUY
$3.25 - $4.28 $1.33 Million - $1.75 Million
408,507 Added 387.39%
513,957 $2.07 Million
Q1 2025

May 13, 2025

BUY
$3.23 - $6.2 $7,429 - $14,260
2,300 Added 2.23%
105,450 $351,000
Q4 2024

Feb 12, 2025

BUY
$5.04 - $6.93 $151,200 - $207,900
30,000 Added 41.01%
103,150 $645,000
Q3 2024

Nov 12, 2024

BUY
$5.33 - $8.36 $389,889 - $611,534
73,150 New
73,150 $408,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $22.3M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.